Training future leaders in ovarian cancer research
Career Enhancement Program (CEP)
This program is all about helping new researchers learn how to study ovarian cancer better, so they can find new ways to diagnose and treat it, and they're looking for diverse candidates from different places in the U.S. to join in!
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Dana-Farber Cancer Inst NIH-funded |
| Lab location | 1 site (Boston, United States) |
| Project ID | NIH-10895329 on NIH RePORTER |
What this research studies
This program aims to enhance the pool of researchers focused on ovarian cancer by training junior faculty members to become independent investigators. It will provide funding and resources to support their development in the areas of pathobiology, diagnosis, treatment, and control of ovarian cancers. The initiative emphasizes diversity among researchers and seeks candidates from various institutions across the U.S. to ensure a broad representation in the field. The program is led by experienced mentors who have a proven track record in ovarian cancer research.
Who could benefit from this research
Good fit: Ideal candidates for participation or benefit from this research are junior faculty members and emerging researchers interested in ovarian cancer.
Not a fit: Patients who are not involved in academic research or are not seeking to become investigators in ovarian cancer may not receive direct benefits from this program.
Why it matters
Potential benefit: If successful, this research could lead to improved understanding and treatment options for ovarian cancer, ultimately benefiting patients through enhanced care and innovative therapies.
How similar studies have performed: Similar programs have successfully increased the number of qualified researchers in various cancer fields, indicating a positive precedent for this approach.
Where this research is happening
Boston, United States
- Dana-Farber Cancer Inst — Boston, United States (Active)
Researchers
- Principal investigator: Castro, Cesar M — Dana-Farber Cancer Inst
- Study coordinator: Castro, Cesar M
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.